Medical specialists from France tagged as investigators in clinical trials studying Gaucher Disease Type 3
Total 2 results
-
Anais Brassier, DoctorSeen in:
- Paris, Hopital Necker - Investigational Site Number: 2500001
Trials:- NCT05222906 (Principal Investigator)
Conditions: -
Nadjar Yann, Dr.Seen in:
- Paris, 47-87, boulevard de l'hôpital - Investigational Site Number: 2500003
Trials:- NCT05222906 (Principal Investigator)
Conditions:
Clinical Trials on Gaucher Disease Type 3
-
AVROBIOWithdrawn
-
KemPharm Denmark A/STerminatedGaucher Disease, Type 1 | Gaucher Disease, Type 3India
-
CANbridge (Suzhou) Bio-pharma Co., Ltd.RecruitingGaucher Disease, Type 1 | Gaucher Disease, Type 3China
-
Genzyme, a Sanofi CompanyActive, not recruitingGaucher Disease Type 1 | Gaucher Disease Type 3Germany, United States, Japan, United Kingdom
-
Baylor Research InstituteTexas Scottish Rite Hospital for ChildrenWithdrawnGaucher Disease Type 1 | Gaucher Disease Type 3United States
-
SanofiRecruitingGaucher's Disease Type IIIUnited States, Germany, Hungary, France, China, Japan, Canada, Argentina, Italy, Turkey
-
ShireCompletedGaucher Disease, Type 3Egypt, India, Tunisia
-
University of MinnesotaRecruitingGaucher Disease, Type 3United States
-
Ari ZimranPfizerActive, not recruitingGaucher Disease, Type 3Israel, Turkey, India
-
University of California, San FranciscoDuke UniversityRecruitingWolman Disease | MPS IVA | Pompe Disease Infantile-Onset | Gaucher Disease, Type 2 | MPS VI | MPS I | Gaucher Disease, Type 3 | MPS II | Mps VIIUnited States